People with type I diabetes have to inject themselves multiple times a day with manufactured insulin to maintain healthy levels of the hormone, as their bodies do not naturally produce enough. The ...
Weekly insulin shots can help control both Type 1 and Type 2 diabetes as well as daily injections do, a pair of clinical trials have found. Photo by Adobe Stock/HealthDay News Weekly insulin shots can ...
A real-world study conducted across 9 European countries found that bolus injection frequency and engagement with a smart pen to administer insulin were associated with improved glycemic control among ...
June 25 (Reuters) - (This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays. To receive the full newsletter in your inbox for free sign ...
A pharmacist holds a box of the drug Lantus SoloStar, made by Sanofi Pharmaceutical, at a pharmacy in Provo (Reuters) - GoodRx said on Thursday it has collaborated with Sanofi to offer the drugmaker's ...
A major challenge for people who have a form of diabetes is the need to regulate the glucose levels in their body. Normally this is where the body’s insulin-producing cells would respond to glucose ...
Once-weekly vs. daily insulin injection: Which is more effective? For the study, the researchers recruited 588 individuals with an average age of 58 years old from 11 countries, including the USA, ...
Novo Nordisk announced that the FDA has approved NovoLog (insulin aspart [rDNA origin] injection) for pregnancy Category B rating. The move follows a review of the largest-ever randomized controlled ...
The report highlights that insulin-derived amyloidosis can mimic other injection-site reactions and should be considered when ...
After the failure of SmartCells "smart insulin" in 2018 I look at such claims very skeptically. The source paper is Pay Per View but the Supplementary Information tells me all I need to know. In the ...
GoodRx announced Thursday morning that it is working with Sanofi on a program to offer one of its leading insulin products to consumers for $35 per month. By visiting ...